Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Revenue | 22M | 27M | 24M | 23M | 21M | 19M |
| Cost of revenue | 4M | 6M | 5M | 5M | 6M | 5M |
| Gross profit | 18M | 21M | 18M | 17M | 15M | 14M |
| Research and development | 7M | 7M | 7M | 7M | 6M | 6M |
| Selling, general and administrative | 5M | 5M | 6M | 15M | 4M | 5M |
| Operating expenses | 24M | 24M | 25M | 22M | 20M | 20M |
| Operating income | −6M | −3M | −7M | −5M | −4M | −6M |
| Net income | −7M | −3M | −9M | −7M | −5M | −8M |
| Earnings per share | −0.20 | −0.11 | −0.26 | −0.21 | −0.19 | −0.26 |
| Earnings per share, diluted | −0.20 | −0.11 | −0.26 | −0.21 | −0.19 | −0.26 |
| Weighted average shares | 34M | 33M | 33M | 31M | 29M | 29M |
| Weighted average shares, diluted | 34M | 33M | 33M | 31M | 29M | 29M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 15M | 22M | 21M | 23M | 27M | 13M | 15M | 13M |
| Short-term investments | 39M | 39M | 39M |
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | −6M | — | — | −7M | — | — |
| Depreciation and amortisation | 60,000 | 100,000 | 100,000 | 49,000 |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 39M |
| 39M |
| 39M |
| 41M |
| 43M |
| Receivables | 15M | 15M | 15M | 14M | 15M | 13M | 12M | 11M |
| Inventory | 17M | 17M | 18M | 16M | 14M | 13M | 12M | 11M |
| Current assets | 87M | 94M | 95M | 94M | 97M | 81M | 83M | 80M |
| Property, plant and equipment | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 998,000 |
| Total assets | 99M | 106M | 107M | 106M | 110M | 95M | 96M | 94M |
| Current liabilities | 16M | 18M | 20M | 17M | 15M | 15M | 15M | 13M |
| Long-term debt | 59M | 59M | 59M | 59M | 60M | 60M | 59M | 59M |
| Total liabilities | 84M | 87M | 89M | 87M | 86M | 87M | 86M | 85M |
| Equity | 14M | 19M | 19M | 19M | 24M | 8M | 10M | 10M |
| Shares outstanding | 34M | 34M | 33M | 33M | 33M | 30M | 30M | 29M |
| Shares issued | 34M | 34M | 33M | 33M | 33M | 30M | 30M | 29M |
| 100,000 |
| 100,000 |
| Share-based compensation | 2M | — | — | 3M | — | — |
| Capital expenditure | 117,000 | — | — | 37,000 | — | — |
| Investing cash flow | −117,000 | — | — | −37,000 | — | — |
| Share buybacks | 0 | — | — | 50M | — | — |
| Financing cash flow | −166,000 | — | — | 21M | — | — |